Log in
|
Specification |
Details |
|
Drug Detected |
Hydrocodone |
|
Cutoff Level |
300 ng/mL |
|
Sample Type |
Human Urine |
|
Test Format |
Dip Test Strip |
|
Technology |
Rapid Immunoassay |
|
Time to Results |
Approximately 5 Minutes |
|
Intended Use |
Professional & Forensic Use Only |
Using the test strip is quick and straightforward:
Remove the test strip from its sealed pouch and use it immediately.
Hold the strip by the labeled end only and avoid touching the test membrane.
Dip the strip vertically into the urine specimen for 10–15 seconds, ensuring the urine level does not exceed the MAX line.
Remove the strip and place it on a clean, dry, non-absorbent surface.
Read the results within 3–5 minutes.
Do not interpret the results after 10 minutes.
Following the recommended testing procedure helps ensure accurate specimen collection and reliable preliminary screening results.
The Hydrocodone Drug Test Strip (300 ng/mL) is suitable for:
Clinical laboratories
Hospitals and healthcare facilities
Prescription compliance monitoring
Pain management clinics
Rehabilitation centers
Substance abuse treatment programs
Workplace drug testing
Occupational health clinics
Law enforcement agencies
Correctional facilities
Forensic laboratories
Professional drug screening services
Hydrocodone is a prescription opioid analgesic used to treat moderate to severe pain. It is commonly prescribed alone or in combination with other medications, such as acetaminophen, to help manage pain following surgery, injury, or chronic medical conditions.
Because hydrocodone acts on opioid receptors in the brain, prolonged or inappropriate use can lead to physical dependence, misuse, or addiction. For this reason, many healthcare providers and organizations include hydrocodone screening as part of prescription monitoring and drug testing programs
Hydrocodone may be prescribed for:
Moderate to severe pain management
Post-operative pain relief
Injury-related pain
Chronic pain management (under medical supervision)
Certain combination prescription pain medications
When used exactly as prescribed, hydrocodone can be an effective medication for pain control
Hydrocodone testing helps healthcare providers and organizations monitor appropriate medication use while supporting workplace safety and substance abuse prevention.
The Hydrocodone Drug Test Strip can assist with:
Prescription compliance monitoring
Pain management programs
Substance misuse screening
Rehabilitation and recovery monitoring
Workplace drug testing
Occupational health screening
Forensic investigations
Court-ordered testing programs
Rapid screening allows professionals to obtain preliminary results quickly while determining whether additional laboratory confirmation is necessary.
The Hydrocodone Drug Test Strip (300 ng/mL) offers several advantages for professional drug screening:
Detects Hydrocodone in human urine
300 ng/mL cutoff for reliable preliminary screening
Results available in approximately 5 minutes
High analytical accuracy
Simple dip-and-read testing procedure
Easy interpretation of results
No specialized laboratory equipment required
Suitable for routine and high-volume testing
Reliable performance for workplace, clinical, rehabilitation, and forensic applications
The Hydrocodone Drug Test Strip (300 ng/mL) provides a fast, accurate, and convenient solution for the preliminary detection of hydrocodone in human urine. With results available in approximately 5 minutes, a 300 ng/mL cutoff level, and a simple dip-and-read format, it supports efficient testing without requiring specialized laboratory equipment.
Its reliable performance, ease of use, and suitability for routine or high-volume screening make it an excellent choice for clinical laboratories, pain management clinics, rehabilitation centers, workplace drug testing programs, occupational health providers, prescription compliance monitoring, and forensic investigations.
To maintain optimal performance:
Store the test strips according to the manufacturer's recommended storage conditions.
Keep each test strip sealed in its original pouch until ready for use.
Use the strip immediately after opening the pouch.
Do not use the product beyond the expiration date.
Protect the test from excessive heat, humidity, and direct sunlight.
Handle urine specimens using appropriate laboratory safety procedures.
Follow all testing instructions carefully for accurate results
The Hydrocodone Drug Test Strip (300 ng/mL) provides preliminary qualitative screening results only.
A positive result indicates the possible presence of Hydrocodone at or above the screening cutoff but does not determine the amount used, the time of use, or the level of impairment.
A negative result does not completely exclude hydrocodone use if the drug concentration is below the cutoff level or outside the detection window.
Individual metabolism, specimen quality, medications, hydration status, and testing procedures may influence results.
Certain medications or substances may interfere with immunoassay screening under specific conditions.
All preliminary positive results should be confirmed using GC-MS or LC-MS/MS before medical, legal, employment, or administrative decisions are made
The test detects Hydrocodone in human urine using a 300 ng/mL screening cutoff
Results are available in approximately 5 minutes when testing is performed according to the instructions
The Hydrocodone Drug Test Strip uses a 300 ng/mL cutoff level, providing reliable preliminary screening for hydrocodone in urine samples
No. This is a qualitative screening test. It indicates whether hydrocodone is present at or above the screening cutoff but does not measure the exact drug concentration or dosage.
No. This test provides preliminary screening results only. Any preliminary positive result should be confirmed using GC-MS or LC-MS/MS before medical, legal, employment, or administrative decisions are made
The Hydrocodone Drug Test Strip is intended for:
Clinical laboratories
Hospitals and healthcare facilities
Pain management clinics
Prescription monitoring programs
Rehabilitation centers
Substance abuse treatment programs
Workplace drug testing providers
Occupational health clinics
Law enforcement agencies
Correctional facilities
Forensic laboratories
Professional drug screening organization
The Hydrocodone Drug Test Strip (300 ng/mL) offers a fast, accurate, and convenient solution for the preliminary detection of Hydrocodone in human urine. Featuring a 300 ng/mL cutoff level, a simple dip-and-read format, and results available in approximately 5 minutes, it provides dependable screening for a wide range of professional testing applications.
Designed for use in clinical laboratories, hospitals, pain management clinics, rehabilitation centers, workplace drug testing programs, occupational health clinics, prescription monitoring programs, law enforcement agencies, correctional facilities, and forensic laboratories, the test delivers reliable preliminary results without requiring specialized laboratory equipment. Its ease of use, rapid turnaround time, and consistent performance make it well suited for both routine and high-volume drug screening.
As with all rapid immunoassay screening devices, any preliminary positive result should be confirmed using Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made. The Hydrocodone Drug Test Strip (300 ng/mL) is intended for professional and forensic use only and is not intended for medical diagnosis or home testing
The Hydrocodone Drug Test Strip (300 ng/mL) is a rapid immunoassay designed for the qualitative detection of Hydrocodone in human urine. With a 300 ng/mL cutoff level, this easy-to-use dip test delivers reliable preliminary screening results in approximately 5 minutes, making it suitable for professional drug testing and monitoring programs.
Hydrocodone is a prescription opioid medication commonly used to relieve moderate to severe pain and is found in a variety of prescription pain medications. Because hydrocodone has the potential for misuse and dependence, rapid screening is often included in prescription monitoring, workplace drug testing, rehabilitation programs, and forensic investigations.
The test utilizes a simple dip-and-read format that requires only a urine specimen and no specialized laboratory equipment. Its straightforward procedure enables trained professionals to perform efficient screening in a wide range of professional settings.
Designed with high analytical accuracy and built-in quality controls, the Hydrocodone Drug Test Strip provides dependable preliminary results while supporting timely decision-making in occupational health, clinical, rehabilitation, and forensic environments.
This product provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using a more specific laboratory confirmation method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made.
The Hydrocodone Drug Test Strip (300 ng/mL) is intended for professional and forensic use only and is not intended for medical diagnosis or self-testing
Hydrocodone
Hydrocodone is generally detectable in urine for approximately 2–4 days after the last dose. Detection times may vary depending on:
Detection windows are approximate and should always be interpreted by qualified professionals
This Hydrocodone Drug Test Strip uses the following screening cutoff:
Hydrocodone: 300 ng/mL
Samples containing hydrocodone at or above this concentration may produce a preliminary positive result and should be confirmed using an appropriate laboratory confirmation method.
A colored line appears in both the Control (C) and Test (T) regions. Even if the Test (T) line appears faint, the result should be interpreted as negative, indicating that the concentration of Hydrocodone is below the 300 ng/mL cutoff level
A colored line appears only in the Control (C) region, while no visible line appears in the Test (T) region. This indicates that the concentration of Hydrocodone may be at or above the 300 ng/mL screening cutoff.
Because this test provides preliminary screening results only, all positive results should be confirmed using a more specific laboratory method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made
If the Control (C) line does not appear, the test is considered invalid, regardless of whether a Test (T) line is visible. This may occur due to insufficient specimen volume, improper testing technique, or a defective test strip.
Hydrocodone Drug Test Strip (300 ng/mL) | Serenity SM-DOA-HCOSCN 25/Box
Sign up for updates from leading retailers
